BioCentury
ARTICLE | Management Tracks

Owkin finds new CBO in Sanofi SVP

Plus CEO Séjourné moves to Aurobac and updates from Quantum, BioHaven and more

October 5, 2022 12:21 AM UTC

AI-based medical research company Owkin Inc. hired Alban de La Sablière as CBO. de La Sablière joins from Sanofi (Euronext:SAN; NASDAQ:SNY) where he was SVP global head of partnering, having previously led the French M&A practice at Morgan Stanley. 

Antibacterial company Aurobac Therapeutics S.A.S. named Florence Séjourné as CEO. Séjourné was CEO at Da Volterra and co-founder of Genfit S.A. (Euronext:GNFT; NASDAQ:GNFT)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article